Can amitriptyline (tricyclic antidepressant) be used to treat sleep disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Amitriptyline can be used to treat sleep disorders, particularly when accompanied by comorbid depression or in cases of other treatment failures, but its use should be considered with caution due to potential side effects and the availability of other treatment options. According to the clinical guideline for the evaluation and management of chronic insomnia in adults 1, sedating low-dose antidepressants like amitriptyline may be considered when other treatments have failed. The guideline notes that evidence for the efficacy of these drugs when used alone is relatively weak, and no specific agent is recommended as preferable to others in this group.

Key Considerations for Amitriptyline Use

  • The selection of amitriptyline should be guided by factors such as treatment history, coexisting conditions, specific side effect profile, cost, and pharmacokinetic profile 1.
  • Amitriptyline is associated with anticholinergic activity, which may be a consideration in certain patients, unlike trazodone which has little or no anticholinergic activity relative to doxepin and amitriptyline 1.
  • Patients should be aware of potential side effects including morning grogginess, dry mouth, constipation, urinary retention, and blurred vision, which are often dose-dependent and may diminish over time.

Non-Pharmacological Approaches

  • Before considering amitriptyline, non-medication approaches like sleep hygiene practices, stimulus control, relaxation training, and cognitive behavioral therapy for insomnia (CBT-I) should be explored, as recommended by the guideline 1.
  • These approaches can be effective in addressing underlying causes of sleep problems and may be used in conjunction with pharmacological treatment.

Patient Monitoring and Safety

  • Amitriptyline should be used cautiously in elderly patients and those with heart conditions, glaucoma, or urinary retention issues.
  • Patients should be monitored for potential side effects, and the dosage should be gradually reduced under medical supervision if discontinuation is necessary.

From the Research

Amitriptyline for Sleep Disorders

  • Amitriptyline, a tricyclic antidepressant, is sometimes used off-label to treat sleep disorders, particularly insomnia 2, 3, 4, 5.
  • Studies have shown that low-dose amitriptyline can improve sleep maintenance in patients with insomnia disorder 2, 5.
  • A cross-sectional study found that 73.9% of patients reported improvement in sleep maintenance, and 45.8% were satisfied with the treatment results 2.
  • Randomized controlled trials have been conducted to assess the effectiveness of low-dose amitriptyline compared to cognitive behavioral therapy for insomnia (CBT-I) 3 and placebo 4, 5.
  • The results of these trials suggest that low-dose amitriptyline can be an effective alternative to CBT-I for treating insomnia in patients with medical comorbidity 3.
  • However, the effectiveness of amitriptyline may vary depending on the dose and duration of treatment, as well as individual patient characteristics 5.
  • Common side effects of amitriptyline include drowsiness, dry mouth, and constipation, but the drug is generally well-tolerated at low doses 2, 5.

Comparison with Other Treatments

  • Low-dose amitriptyline has been compared to mirtazapine, another antidepressant, in the treatment of insomnia disorder 4, 5.
  • One study found that mirtazapine was more effective than amitriptyline in reducing insomnia severity at 6 weeks, but the difference was not significant at later time points 5.
  • Another study found that amitriptyline was effective in reducing symptoms of functional dyspepsia, including poor sleep, but the mechanism of action was unclear 6.

Patient-Reported Outcomes

  • Patient-reported outcomes are an important aspect of assessing the effectiveness of amitriptyline for sleep disorders 2, 5.
  • Studies have used questionnaires such as the Insomnia Severity Index (ISI) to assess patient-reported outcomes, including sleep quality, daytime functioning, and treatment satisfaction 2, 5.
  • The results of these studies suggest that patients with insomnia disorder can experience significant improvements in sleep quality and daytime functioning with low-dose amitriptyline treatment 2, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.